摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-fluoro-4-(methylsulphenyl)toluene | 142994-08-9

中文名称
——
中文别名
——
英文名称
2-fluoro-4-(methylsulphenyl)toluene
英文别名
2-fluoro-1-methyl-4-methylsulfanylbenzene;2-Fluoro4-(methylsulphenyl)-toluene;2-fluoro-4-methylsulphenyltoluene;3-Fluoro-4-methylphenyl methyl sulfide
2-fluoro-4-(methylsulphenyl)toluene化学式
CAS
142994-08-9
化学式
C8H9FS
mdl
MFCD11617748
分子量
156.224
InChiKey
GXBXPURGSKUHHB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    25.3
  • 氢给体数:
    0
  • 氢受体数:
    2

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] SUBSTITUTED QUINAZOLINES AS FUNGICIDES<br/>[FR] QUINAZOLINES SUBSTITUÉES, UTILISÉES EN TANT QUE FONGICIDES
    申请人:SYNGENTA PARTICIPATIONS AG
    公开号:WO2010136475A1
    公开(公告)日:2010-12-02
    The present invention relates to a compound of formula (I) wherein wherein the substituents have the definitions as defined in claim 1or a salt or a N-oxide thereof, their use and methods for the control and/or prevention of microbial infection, particularly fungal infection, in plants and to processes for the preparation of these compounds.
    本发明涉及一种具有如下式(I)的化合物,其中取代基具有权利要求1中定义的定义,或其盐或N-氧化物,它们的用途以及用于控制和/或预防植物中微生物感染,特别是真菌感染的方法,以及制备这些化合物的方法。
  • SUBSTITUTED QUINAZOLINES AS FUNGICIDES
    申请人:Quaranta Laura
    公开号:US20120129875A1
    公开(公告)日:2012-05-24
    The present invention relates to a compound of formula (I) wherein the substituents have the definitions as defined in claim 1 or a salt or a N-oxide thereof, their use and methods for the control and/or prevention of microbial infection, particularly fungal infection, in plants and to processes for the preparation of these compounds.
    本发明涉及一种具有如权利要求1中定义的取代基定义的化合物的公式(I),或其盐或N-氧化物,它们的用途以及用于控制和/或预防植物中微生物感染,特别是真菌感染的方法,以及制备这些化合物的方法。
  • PYRROLOPYRIMIDINES AS CFTR POTENTIATORS
    申请人:CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC.
    公开号:US20180141954A1
    公开(公告)日:2018-05-24
    The present invention relates to compounds of Formula I, wherein R 1a , R 1b , R 2 , R 3 , R 4 , W, Y, and Z are as described herein, and pharmaceutically acceptable salts thereof. The compounds are potentiators of Cystic Fibrosis Transmembrane conductance Regulator (CFTR). The invention also discloses pharmaceutical compositions comprising the compound, optionally in combination with additional therapeutic agents, and methods of potentiating, in mammals, including humans, CFTR by administration of the compounds. These compounds are useful for the treatment of cystic fibrosis (CF), asthma, bronchiectasis, chronic obstructive pulmonary disease (COPD), constipation, Diabetes mellitus, dry eye disease, pancreatitis, rhinosinusitis, Sjögren's Syndrome, and other CFTR associated disorders.
    本发明涉及式I的化合物,其中R1a、R1b、R2、R3、R4、W、Y和Z如本文所述,并且其药学上可接受的盐。这些化合物是囊性纤维化跨膜传导调节器(CFTR)的增效剂。本发明还揭示了包括该化合物的药物组合物,可选地与额外治疗剂结合,并通过给予这些化合物来增强哺乳动物(包括人类)CFTR的方法。这些化合物可用于治疗囊性纤维化(CF)、哮喘、支气管扩张、慢性阻塞性肺病(COPD)、便秘、糖尿病、干眼症、胰腺炎、鼻窦炎、Sjögren综合征和其他与CFTR相关的疾病。
  • [EN] BENZODIAZEPINE DERIVATIVES USEFUL IN TREATING A RESPIRATORY SYNCYTIAL VIRUS INFECTION<br/>[FR] DÉRIVÉS DE BENZODIAZÉPINE UTILES POUR LE TRAITEMENT D'UNE INFECTION PAR LE VIRUS RESPIRATOIRE SYNCYTIAL
    申请人:REVIRAL LTD
    公开号:WO2022008911A1
    公开(公告)日:2022-01-13
    Benzodiazepine derivatives of formula (Ie) wherein one of R1 and R2 is a benzodiazepinyl-containing group of formula (II) in which R8 is H or halo; the other of R1 and R2 is a group Z selected from H, C3-C6 cycloalkyl, halo, -NHR9, benzyl, phenyl, 4- to 10-membered heterocyclyl and 4- to 10-membered heteroaryl, wherein phenyl, heterocyclyl and heteroaryl are unsubstituted or substituted by one or two substituents selected from 4- to 10-membered heterocyclyl which is unsubstituted or substituted by OR, and from C1-C6 alkyl, C1-C6 hydroxyalkyl, C1-C6 haloalkyl, C3-C6 cycloalkyl, halo, -OR, -(CH2)mOR, -NR2, -(CH2)mNR2, -NHR", -SOmNR2, -SOmR, -SR, nitro, -CO2R, -CN, -CONR2, -NHCOR, -CH2NR10R11 and -NR10R11, in which each R is independently H or C1-C6 alkyl, R" is C3-C6 cycloalkyl and m is 1 or 2; R9 is selected from phenyl and 4- to 10-membered heteroaryl wherein phenyl and heteroaryl are unsubstituted or substituted by halo; R10 and R11 are each independently H or C1-C6 alkyl; or R10 and R11 form, together with the N atom to which they are attached, either (a) a morpholine ring which is optionally bridged by a -CH2- group linking two ring carbon atoms that are positioned para to each other, or (b) a spiro group of the following formula (b): and ring A is a ring of one of the following structural formulae (I-1), (I-2) and (I-3): and ring A is a ring of one of the following structural formulae (I-1), (1-2) and (1-3): in which Y is selected from O, S, SO2 and NR, wherein R is as defined above, and each of R2 to R7 is independently H, C1-C6 alkyl, C1-C6 hydroxyalkyl, C3-C6 cycloalkyl, halo, -OR, -CH2OR, -NR2, -CH2NR12R13, -NRCOOR, -CH2OR, -SOmNR2, -SOmR, - CH2SOmR, nitro, -CO2R, -CN, -CONR2 or -NHCOR, in which R and m are as defined above and R12 and R13 are each independently H, C1-C6 alkyl, benzyl, 4- to 10-membered heterocyclyl or R12 and R13 form, together with the N atom to which they are attached, a 4- to 10-membered heteroaryl which is unsubstituted or a 4- to 10-membered heterocyclyl which is unsubstituted or substituted with C1-C6 alkyl or halo, or any two of R2 to R7 that bond to the same carbon atom form a spiro ring selected from a C3-C6 cycloalkyl spiro ring and a spiro oxetane ring of the following structure: (Formula A) and the pharmaceutically acceptable salts thereof are inhibitors of RSV and can therefore be used to treat or prevent an RSV infection.
    苯二氮卓啉衍生物的化学式(Ie),其中R1和R2中的一个是具有化学式(II)的苯二氮卓啉基团,其中R8为H或卤素;另一个是从H、C3-C6环烷基、卤素、-NHR9、苄基、苯基、4-到10元杂环烷基和4-到10元杂芳基中选择的基团Z,其中苯基、杂环烷基和杂芳基未被取代或被一个或两个取代基取代,所述取代基从未被取代或被OR取代的4-到10元杂环烷基和从C1-C6烷基、C1-C6羟基烷基、C1-C6卤基烷基、C3-C6环烷基、卤素、-OR、-(CH2)mOR、-NR2、-(CH2)mNR2、-NHR"、-SOmNR2、-SOmR、-SR、硝基、-CO2R、-CN、-CONR2、-NHCOR、-CH2NR10R11和-NR10R11中选择,其中每个R独立地为H或C1-C6烷基,R"为C3-C6环烷基,m为1或2;R9从苯基和4-到10元杂芳基中选择,其中苯基和杂芳基未被取代或被卤素取代;R10和R11各自独立地为H或C1-C6烷基;或R10和R11与它们连接的N原子一起形成(a)可以由连接两个对位的环碳原子的-CH2-基团桥接的吗啡环,或(b)下列化学式(b)的螺环团,其中环A是以下结构式(I-1)、(I-2)和(I-3)之一的环,环A是以下结构式(I-1)、(1-2)和(1-3)之一的环,其中Y从O、S、SO2和NR中选择,其中R如上定义,R2到R7中的每一个独立地为H、C1-C6烷基、C1-C6羟基烷基、C3-C6环烷基、卤素、-OR、-CH2OR、-NR2、-CH2NR12R13、-NRCOOR、-CH2OR、-SOmNR2、-SOmR、-CH2SOmR、硝基、-CO2R、-CN、-CONR2或-NHCOR,其中R和m如上定义,R12和R13各自独立地为H、C1-C6烷基、苄基、4-到10元杂环烷基或R12和R13与它们连接的N原子一起形成未被取代的4-到10元杂芳基或未被取代或被C1-C6烷基或卤素取代的4-到10元杂环烷基,或结合到同一碳原子的R2到R7中的任意两个形成以下结构的螺环:(化学式A),及其药学上可接受的盐是RSV的抑制剂,因此可以用来治疗或预防RSV感染。
  • Herbicidal 4-acyl-5-aryl isoxazole derivatives
    申请人:Rhone-Poulenc Argriculture Ltd
    公开号:US05366957A1
    公开(公告)日:1994-11-22
    5-Aryl isoxazole derivatives of formula (I): ##STR1## wherein: Ar represents phenyl optionally substituted substituted by one or more groups R.sup.2 ; R represents hydrogen, --CO.sub.2 R.sup.3, --COR.sup.4, cyano, halogen, alkyl or haloalkyl; R.sup.1 represents alkyl, haloalkyl or cycloalkyl; R.sup.2 represents a halogen atom, R.sup.4, nitro, --CO.sub.2 R.sup.3, --OR.sup.4, --S(O).sub.m R.sup.4, --S(O).sub.m R.sup.5, --O--(CH.sub.2).sub.p --OR.sup.4 or an alkyl group substituted by --OR.sup.4 ; R.sup.3 and R.sup.4, which may be the same or different, each represent alkyl or haloalkyl; R.sup.5 represents optionally substituted phenyl; p represents an integer from 1 to 3; and m represents zero, 1 or 2; the herbicidal properties of these derivatives and their application to crop protection is described.
    式(I)的5-芳基异噁唑衍生物:其中:Ar代表苯基,可选择性地被一个或多个基团R.sup.2取代;R代表氢,-CO.sub.2R.sup.3,-COR.sup.4,氰基,卤素,烷基或卤代烷基;R.sup.1代表烷基,卤代烷基或环烷基;R.sup.2代表卤素原子,R.sup.4,硝基,-CO.sub.2R.sup.3,-OR.sup.4,-S(O).sub.mR.sup.4,-S(O).sub.mR.sup.5,-O-(CH.sub.2).sub.p-OR.sup.4或被-OR.sup.4取代的烷基基团;R.sup.3和R.sup.4,可以相同也可以不同,每个代表烷基或卤代烷基;R.sup.5代表可选择性取代的苯基;p代表1到3之间的整数;m代表零,1或2;描述了这些衍生物的除草性能及其在作物保护中的应用。
查看更多